| Structure | Chemical Name | CAS | MF |
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
4-(1-PHENYL-2-(3-PHENYLUREIDO)ETHOXY)BENZO[B]THIOPHENE-2-CARBOXIMIDAMIDE
|
1057337-39-9
|
C24H22N4O2S
|
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-3-CARBOXYLATE
|
1007473-53-1
|
C27H28N6O4
|
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-O-TOLYL-1H-PYRAZOLE-3-CARBOXYLATE
|
1007477-05-5
|
C29H31N5O4
|
|
|
n/a
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
ETHYL 1-(2-CHLOROPHENYL)-5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
|
1007483-08-0
|
C28H28ClN5O4
|
|
|
Pf-868554
|
877225-09-7
|
|
|
1-(4-(4-(5-Methyl-3-phenylisoxazole-4-carbonyl)piperazin-1-yl)phenyl)ethanone
|
941104-13-8
|
C23H23N3O3
|
|
4-(3-ethyl-5-Methylisoxazole-4-carbonyl)-1-(4-Methoxyphenyl)-6,6-diMethylpiperazin-2-one
|
1060929-26-1
|
C20H25N3O4
|
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
|
1007477-89-5
|
C28H28FN5O4
|
|
|
NA
|
|
|
|
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3S,4S)-
|
905854-03-7
|
C23H19N3O2
|
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
|
1007477-32-8
|
C28H28FN5O4
|
|
1-PropanaMine, 3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-iMidazol-4-yl]phenoxy]-N,N-diethyl-
|
603148-36-3
|
C32H38ClN3O2
|
|
Tivantinib (ARQ 197)
|
905854-02-6
|
C23H19N3O2
|
|
Mk-2461 .
|
917879-39-1
|
C24H25N5O5S
|
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
|
1007482-89-4
|
C29H31N5O5
|
|
cis-4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexaneacetic acid
|
701234-65-3
|
C22H26N4O3
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
Zimeldine
|
|
|
|
|
Lymphocyte separation media
|
|
|
|
|
TetrabutylAmmoniumhydroxide
|
|
|
|
|
Ginsenoside Rg2
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
N/A
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
PTMC
|
|
|
|
|
difluoroethane
|
|
C2H4F2
|
|
|
Polyneopenthylglycoladipate
|
|
|
|
|
N-Acetyl-2-naphthylamin
|
|
C12H11NO
|
|
|
2-chloro-1-1’-dimethylbiphenyl
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
3-chloro-4'-methoxy propiophenone
|
|
|
|
|
3-Chloro-6-fluorobenzaldehyde
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
|
NA
|
|
|
|
Sodium Stannate Trihydrate
|
12009-98-2
|
Na2SnO3·3H2O
|
|
Thiophosphoric acid O,O-diethyl S-benzyl ester
|
13286-32-3
|
C11H17O3PS
|
|
|
NA
|
|
|
|
|
NA
|
|
|